Meningitis Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Meningitis stocks.

Meningitis Stocks Recent News

Date Stock Title
Jul 5 SNY Pharma Stock Roundup: FDA Nod to LLY's Kisunla, SNY's Dupixent Gets EU Nod for COPD
Jul 5 SNY Dupixent “addresses current gap” in COPD biologics landscape
Jul 4 GSK Should We Be Delighted With GSK plc's (LON:GSK) ROE Of 36%?
Jul 4 SNY French State Investment Firm Eyes Stake in Sanofi Consumer Unit
Jul 3 PCRX Pacira downgraded at Barclays following generic Exparel approval
Jul 3 GSK GSk snaps six straight days of losses
Jul 3 SNY Update: Market Chatter: Bain, Cinven Said to Weigh Joint Bid for Sanofi's Consumer Health Division
Jul 3 SNY Bain, Cinven Weighing Joint Bid for $20 Billion Sanofi Unit
Jul 3 SNY Europe Approves Sanofi/Regeneron's Dupixent for 'Smoker's Lungs' A Month After US FDA Asks For Data
Jul 3 SNY Regeneron (REGN), SNY Win EC Approval for Dupixent for COPD
Jul 3 GSK GSK Buys Full Rights To Investigational Covid-19 And Influenza Vaccines From CureVac For Around $1.5B
Jul 3 SNY Sanofi, Regeneron win EU label expansion for Dupixent in COPD
Jul 3 SNY EMA approves Sanofi’s Dupixent for COPD treatment in adults
Jul 3 GSK GSK to Buy CureVac’s Covid-19, Flu Vaccine Rights for Up to $1.56 Billion
Jul 3 SNY Update: Market Chatter: Delaware Judge Rejects Drugmakers' Appeal to End Zantac Lawsuits
Jul 3 GSK Trending tickers: SoftBank, Reddit, Vodafone, GSK
Jul 3 GSK 3 No-Brainer Stocks to Buy With $300 Right Now for the Second Half of 2024
Jul 3 GSK CureVac to cut 30% of workforce as GSK buys rights to make flu, covid shots
Jul 3 SNY Press Release: Dupixent approved in the EU as the first-ever targeted therapy for patients with COPD
Jul 2 PCRX Pacira down 25% as FDA approves generic version of Exparel
Meningitis

Meningitis is an acute inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges. The most common symptoms are fever, headache, and neck stiffness. Other symptoms include confusion or altered consciousness, vomiting, and an inability to tolerate light or loud noises. Young children often exhibit only nonspecific symptoms, such as irritability, drowsiness, or poor feeding. If a rash is present, it may indicate a particular cause of meningitis; for instance, meningitis caused by meningococcal bacteria may be accompanied by a characteristic rash.The inflammation may be caused by infection with bacteria, other microorganisms, or viruses, and less commonly by certain drugs. Meningitis can be life-threatening because of the inflammation's proximity to the brain and spinal cord; therefore, the condition is classified as a medical emergency. A lumbar puncture, in which a needle is inserted into the spinal canal to collect a sample of cerebrospinal fluid (CSF), can diagnose or exclude meningitis.Some forms of meningitis are preventable by immunization with the meningococcal, mumps, pneumococcal, and Hib vaccines. Giving antibiotics to people with significant exposure to certain types of meningitis may also be useful. The first treatment in acute meningitis consists of promptly giving antibiotics and sometimes antiviral drugs. Corticosteroids can also be used to prevent complications from excessive inflammation. Meningitis can lead to serious long-term consequences such as deafness, epilepsy, hydrocephalus, or cognitive deficits, especially if not treated quickly.In 2017, meningitis occurred in about 10.6 million people worldwide. This resulted in 288,000 deaths—down from 464,000 deaths in 1990. With appropriate treatment the risk of death in bacterial meningitis is less than 15%. Outbreaks of bacterial meningitis occur between December and June each year in an area of sub-Saharan Africa known as the meningitis belt. Smaller outbreaks may also occur in other areas of the world. The word meningitis comes from the Greek μῆνιγξ meninx, "membrane", and the medical suffix -itis, "inflammation".

Browse All Tags